Medical valve connector

Information

  • Patent Grant
  • 9707346
  • Patent Number
    9,707,346
  • Date Filed
    Friday, October 11, 2013
    11 years ago
  • Date Issued
    Tuesday, July 18, 2017
    7 years ago
Abstract
Disclosed herein is a valve assembly comprising a male luer end portion and a female luer end portion and a passage for the transfer of fluids extending between the male and female luer end portions, valve means movable between a first position, in which the passage is closed, and a second position, in which the passage is open, biasing means for biasing the valve means toward the first position, and actuating means extending into the male luer end portion and coupled to the valve means to actuate the valve means when a female luer end portion of a medical accessory is engaged with the male luer end portion.
Description
BACKGROUND OF THE INVENTION

Field of the Invention


The present invention relates to medical fluid delivery valves and more particularly to valve assemblies for use with syringes or other medical dispensing devices.


Description of the Related Art


Syringes are commonly used to deliver medications and other biological fluids to a patient. The syringe typically has a plunger which is sealingly engaged with an outer cylindrical chamber to form an inner fluid-receiving chamber. A ‘male’ luer fitting is usually provided at a delivery end of the chamber which receives a female luer fitting with a needle assembly or the like. The fluid channel joining the cavity to the luer fitting is usually open, so that when the needle is removed, the cavity is open to the environment. This is problematic since many medications and biological fluids are sensitive (or can degrade when exposed) to the environment.


It is therefore an object of the present invention to provide a novel valve assembly for use with a syringe or other medical dispensing devices, enabling the latter to be closed to the environment when in an unattached condition.


SUMMARY OF THE INVENTION

In one of its aspects, the present invention provides a valve assembly comprising a male luer end portion, a female luer end portion and a channel for the transfer of fluids between the male and female luer end portions, valve means movable between a closed position and an open position, biasing means for biasing the valve means toward the closed position, and actuating means extending into the male luer end portion and coupled to the valve means to actuate the valve means when a female luer end portion of a medical accessory is coupled with the male luer end portion.


In an embodiment the male luer end portion has an inner projection and outer threaded sheath which is spaced therefrom to receive the female luer end portion therebetween. The actuating means includes an actuating member positioned between the outer threaded sheath and the inner projection.


In an embodiment, the valve means includes a valve seat and a valve member moveable relative thereto. The channel includes a first channel portion adjacent the female luer end portion and the inner projection includes a second channel portion. The valve member has a valve channel portion in fluid communication with the first and second channel portions. The valve seat is formed in the second channel portion and the valve member is integrally formed with the female luer end portion.


In one embodiment, the valve member includes an anchor flange extending outwardly toward an inner surface of the housing portion. In this case, the housing portion is coupled to the male luer end portion for movement therewith relative to the valve member. The male luer end portion engages the anchor flange when the valve means is in the closed position and the male luer end portion is spaced from said anchor flange when the valve means is in the open position. The housing portion terminates at an end region adjacent the female luer end portion, the biasing means includes a compression spring located within the housing between the end region and the outer anchor flange.


In another of its aspects, the present invention provides a medical dispensing device comprising a body having a chamber therein to contain a fluid material, a valve assembly in fluid communication with the chamber, the valve assembly having a male coupling member for engaging a female coupling member on a medical accessory to form a fluid coupling between the medical dispensing device and the medical accessory, the valve assembly further comprising flow control means operable to control fluid flow through the male coupling member, the flow control means being operable to be displaced by the female coupling member to open the male coupling member when female coupling member is operatively connected therewith, the flow control means being operable to be displaced by the female coupling member to close the male coupling member when the female coupling member is disconnected therefrom.


In one embodiment, the male coupling member includes an inner male portion and an outer sheath portion spaced therefrom to form a passage there between for receiving the female coupling member, the flow control means including at least one valve actuating portion positioned in the passage to abut the female coupling member and to displace the valve member during the travel of the female coupling member along the passage. The valve assembly includes a valve member and a valve seat, wherein the valve member is positioned against the seat to close the male coupling member. The valve actuating portion includes a pair of abutment elements which are spaced from one another along the passage to receive the female coupling member there between, wherein the pair of abutment elements are operable to travel with the female coupling member along the passage.


In one embodiment, the actuating portion is longitudinally oriented relative to the passage and the abutment elements are positioned along the actuating portion.


The valve member includes a back plate and a plurality of actuating portions equally spaced on the back plate, each of the actuating portions having first and second abutment elements.


In one embodiment, the valve actuating portion includes a locking flange which is adjacent one of the abutment elements. The valve assembly includes a locking seat to receive the locking flange when the male coupling member is in the closed position. The actuating portion has a distal end region, the locking flange being located adjacent the distal end region and the locking seat is formed in the outer sheath portion. The actuating portion is thus arranged to flex in order to displace the locking flange from the locking seat.


In yet another aspect, the present invention provides a medical dispensing device comprising a body having a chamber therein to contain a fluid material, a valve assembly in fluid communication with the chamber, the valve assembly having a male coupling member for engaging a female coupling member on a medical accessory to form a fluid coupling between the medical dispensing device and the medical accessory, the male coupling member including a projection and an outer valve member movable relative to the projection, the projection and the outer valve member forming a fluid channel there between, a sheath portion encircling the projection and spaced therefrom to form a passage to receive the female coupling member, the valve member being engageable with the female coupling member and movable relative to the projection to open the fluid channel when the female coupling member is connected with the male coupling member.


In one embodiment, the valve member forms an outer surface of the male coupling portion.


In an embodiment, biasing means is provided to bias the valve member toward an engaged position with the projection to close the fluid channel. In this particular case, the passage ends at an inner wall and the biasing means includes a spring located between the inner wall and the valve member.


In one embodiment, the projection is fixed to the body and includes an inner passage, the inner passage having one end which is open to the chamber and another end which is open to the fluid channel. The projection also includes an enlarged end portion, the valve member including an outer portion arranged to engage the enlarged end portion to close the fluid channel. In this case the enlarged end portion and the outer end portion on the valve member have mating bevelled surfaces.


In one embodiment, the female coupling member has a leading segment, the valve member being dimensioned to fit within the leading segment.


Preferably, the medical dispensing device includes such items as a syringe, an IV bottle, an IV line, a powder and/or atomized fluid and/or gas inhalant dispenser, an implant delivery dispenser, a ventilator, a syringe pump, an intubation tube, a gastrointestinal feeding tube or a plurality and/or a combination thereof.


Preferably, the medical material is in solid, liquid or gaseous form or a combination thereof and has beneficial properties to enhance life, to promote health, to cure and/or treat a disease, condition or ailment, to monitor and/or indicate a bodily function or a combination thereof. For example, the medical material may be useful for, among others, IV therapy, implantation, stem cell therapy, oncology therapy, blood transfusion and/or organ transplantation.





BRIEF DESCRIPTION OF THE DRAWINGS

Several preferred embodiments of the present invention will now be described, by way of example only, with reference to the appended drawings in which:



FIG. 1 is a perspective view of a syringe assembly;



FIG. 2 is a sectional view of a portion of the assembly of FIG. 1;



FIGS. 3 and 4 are sectional views of the assembly of FIG. 1 in two alternate operative positions;



FIG. 5 is a fragmentary sectional perspective view of a portion of another syringe assembly;



FIGS. 6 and 7 are fragmentary perspective views of another syringe assembly;



FIGS. 8 to 12 are fragmentary sectional views of the syringe assembly of FIG. 6;



FIG. 13 is a fragmentary perspective view of yet another syringe assembly; and



FIGS. 14 and 15 are fragmentary sectional views of the syringe assembly of FIG. 13 or portions thereof.





DESCRIPTION OF THE PREFERRED EMBODIMENTS

Referring to the figures, and in particular FIG. 1, there is provided a syringe assembly 10 comprising a syringe 12 and a valve unit 14. The syringe 12 has a chamber 20 containing a plunger 22 to form a cavity 24. Referring to FIG. 2, the cavity has an outlet 26 and the valve unit 14 is located downstream of the outlet 26 for coupling the cavity 24 with a medical accessory such as a needle 30 (as shown in FIGS. 3 and 4). The valve unit 14 has an outlet 32 and flow control means, as will be described, to control fluid flow through the outlet, the flow control means being operable to open the outlet when the coupling section is operatively connected with the medical accessory, the flow control means being operable to close the outlet when the valve unit is disconnected from the medical accessory and to remain closed until connected once again with a medical accessory.


In this case, the chamber 20 includes a first male luer end portion 34 adjacent the outlet 26 and the valve unit 14 includes a first female luer end portion 36 which is engageable with the male luer end portion 34. The valve unit 14 also includes a second male luer end portion 38 for coupling with the medical accessory 30.


Although the chamber 20 and the valve unit 14 are separate from one another in this case, it will be understood that they may, alternatively, be integrally formed, for example by combining the first male luer end portion 34 with the female luer end portion 36.


The valve unit 14 has a channel 42 for the transfer of fluids between the female and male luer end portions 36, 38. A valve means, in the form of a valve member 44 is located in the valve unit 14 and is movable between a first position (as shown in FIG. 2), in which the channel is closed, and a second position (as shown in FIG. 3), in which the channel is open. An actuating means, in the form of an actuating member 46 (shown in FIG. 2), extends outwardly from the valve member 44 and into the male luer end portion 38. The actuating member 46 is coupled to the valve member 44 to actuate it when a female luer end portion of the medical accessory 30 is engaged with the male luer end portion 38.


In the embodiment of FIGS. 1 to 4, the male luer end portion 38 has an outer threaded sheath 50 which is spaced from an inner projection 52. In this case, the actuating member 46 is positioned between the outer threaded sheath 50 and the inner projection 52. The valve member 44 includes a valve plug portion 54 moveable relative to a valve seat portion 56. The valve member 44 has an upper end which is integrally aimed with the female luer end portion 36. An outer housing member 58 is slidably mounted on the valve member 44. In this case, the outer housing member 58 is joined to the male luer end portion 38. The valve member 44 also has a valve channel 44a extending from the female luer end portion 36 to the valve plug portion 42 where it terminates at one or more transverse flow openings 44b to join with the channel 42.


The valve member 44 includes an anchor flange 60, and the male luer end portion 38 seats, directly or indirectly, against the anchor flange 60 when the valve is in the closed position as viewed in FIG. 2. Conversely, the male luer end portion 38 is spaced from said anchor flange when the valve is in the open position as shown in FIG. 3.


The outer housing 58 terminates at a radially inwardly directed end region 62 adjacent the female luer end portion 34 and a biasing means in the form of a compression spring 64 is located within the outer housing between the end region 62 and the anchor flange 60 to bias the valve member toward the first position to close the valve unit.


An alternative arrangement is shown in FIG. 5. In this case, the valve unit 70 has a housing 72 which is integrally formed with the female luer end portion 74. A first channel portion 76 is adjacent the female luer end portion 74 and a second channel portion 78 is adjacent a male luer end portion 80. In this case, the valve means includes a valve member 82 having a valve channel 84 in fluid communication with the first and second channel portions 76 and 78. In this case, the valve seat portion is formed at 90 in the second channel portion 78.


The valve member 82 includes a plug portion 92 which is movable relative to and within the second channel portion 78 for engaging the seat portion 90 to close the second channel portion 78. The first channel portion 76 includes a tubular projection 94 extending from the female luer end portion 74. In this case, the valve channel 84 in the valve member 82 is coextensive with the first and second channel portions 76, 78. In this case, the tubular projection 94 is slidably engaged with the valve member 82 within the valve channel 84 and sealed therein by way of seal 98. Likewise, the valve member 84 is sealed within the second channel portion 78 by way of seal 100.


The syringe assembly 10 is used as follows. First, the valve unit 14 is joined to the syringe 12 by engaging the corresponding first male luer end portion 34 with the female luer end portion 36. In this condition, the second male luer end portion 38 is unattached with a medical accessory such as the needle 30 and the actuator 46 is fully extended into the second male luer end portion 38 as shown in FIG. 2. Consequently, the valve member 44 is biased to its closed position, thereby engaging the valve plug portion 54 against the valve seat 56.


The needle 30 is then attached to the syringe by engaging the female luer end portion on the needle 30 with the second male luer end portion 38. Doing so causes the female luer end portion on the needle 30 to abut and displace the actuating member 46, thereby causing the valve member 44 to be displaced upwardly (as viewed in FIG. 2) thereby releasing the valve plug portion 54 from its sealed abutment with the valve seat 56 to open the valve channel. The plunger 22 may then be displaced outwardly to cause fluids in the proximity of the pointed end of the needle 30 to be drawn into the cavity 24, by a path starting at the valve seat 56 through the channel 42 to the transverse flow openings 44b, to the valve channel 44a and on through the female luer end portion and into the cavity 24. The needle 30 may then be removed causing the actuating member 46 to be displaced downwardly (as viewed in FIG. 2) causing the immediate displacement of the valve plug portion to abut the seat 56 and thereby close the valve.


Another device is shown at 120FIGS. 6 to 12, having a body 122 forming an inner chamber 124 therein to contain a fluid material. A valve assembly 126 is in fluid communication with the chamber 124 and has a male coupling member 128 for engaging a female coupling member 130 on a medical accessory (in this case a needle 132) to form a fluid coupling between the device 120 and the needle 132.


The valve assembly 126 is operable to control fluid flow through the male coupling member 128 and more particularly to be in an open position when the male coupling member 128 is operatively connected with the female coupling member 130 and, conversely, to be in a closed position when the male coupling member 128 is disconnected from the female coupling member 130.


In this case, the body 122 and the valve assembly 126 are integrally formed and, as seen in FIG. 8, the latter includes a valve member 134 and a valve seat 136. The valve member 134 is shown in its position against the valve seat 136 to close the male coupling member 128, but for a very minor gap there between for illustrative purposes only.


The male coupling member 128 includes an inner male portion 140 having an inner fluid channel 140a and an outer sheath portion 142 spaced from the inner male portion 140 to form a passage 144 there between for receiving the female coupling member 130. At least one, in this case three, valve actuating portions 146 (two being shown in FIG. 7) are positioned in the passage 144 to abut the female coupling member 130 and to displace the valve member during the travel of the female coupling member 130 along the passage 144. In this case, each valve actuating portion 146 is integrally formed with the valve member 134.


Each valve actuating portion 146 includes a pair of abutment elements 150, 152 which are spaced from one another along the passage 144 to receive the female coupling member 130 there between and to travel with the female coupling member along the passage 144. The abutment element 152 has a bevelled outer surface 152a for reasons to be described. Each actuating portion 146 is longitudinally oriented relative to the passage 144 and the abutment elements 150, 152 are positioned along the actuating portion 146.


Each valve actuating portion 146 includes a locking flange 154 and the valve assembly includes a locking seat 156 to receive the locking flange 154 when the valve member 134 is in the closed position. In this case, the actuating portion 146 has a distal end region and the locking flange 154 is located in the distal end region, while the locking seat 156 is formed in the outer sheath portion 142.


It will be seen in FIG. 10 that each actuating portion 146 is arranged to flex in order to displace the locking flange 154 out of the locking seat 156.


Referring to FIG. 8, the valve member 134 includes a back plate 160 and the actuating portions 146 are equally spaced on the back plate 160. The back plate 160 has a central fluid channel 162 which is in fluid communication with the chamber 124 and the valve member 134 has a fluid channel 163 therein in fluid communication with the central fluid channel 162 and hence the chamber 124. In addition, the fluid channel 163 has a lateral portion 163a which establishes fluid communication between the fluid channel 163 and an inner fluid channel 140a in the inner male portion.


The device 120 is thus used as follows. The valve assembly is set with the valve member in its closed position, that is with the valve member 134 in its position against the valve seat 136 as shown in FIG. 8. The female coupling member 130 on the needle 132 is aligned with the passage 144 and brought toward the male coupling member 128. The bevelled leading surface 152a on the abutment member 152 aids to centre the female coupling member on the mouth of the passage 144. With the locking flange 154 in the locking seat 156, the female coupling member 130 is able to pass the lowermost edge of the abutment element 152 and continue into the passage 144 until the female coupling member makes contact with the abutment element 150 as seen in FIG. 9. As seen in FIG. 10, continued inward force on the female coupling member is transferred to the abutment element 150 causing the abutment portion 146 to move inwardly along the passage and thus to draw the locking flange 154 from this locked position in the locking seat 156, causing the abutment portion 146 to flex, until the locking flange 154 is removed from the locking seat 156. At this position, it can be seen that the valve member 134 has moved from the valve seat 136 to open the fluid channel 163 to the needle 132.


Referring to FIG. 11, as the female coupling member 130 is removed from the passage 144, it makes contact with the abutment element 152 and causes the abutment portion 146 to move outwardly along the passage 144 and thus cause the valve member 134 to move toward the valve seat 136. The locking flange 154 approaches, and finally enters, the locking seat 156 to coincide with the closure of the valve assembly.


Thus, the device 120 does not make use of a valve member which is biased to its closed position as with the earlier embodiment, but rather relies on the displacement of the female coupling member 130 to draw the valve assembly to its closed position when it is removed from the male coupling member 128.


Another device is shown at 170 in FIGS. 13 to 15, having a body 172 providing a chamber 174 therein to contain a fluid material. A valve assembly 176 is in fluid communication with the chamber 174 and has a male coupling member 178 for engaging a female coupling member 180, again on a needle 181, to form a fluid coupling between the medical dispensing device 170 and the needle 181.


The valve assembly 176 is operable to control fluid flow through the male coupling member and more particularly to actuate or open the male coupling member 178 when operatively connected with the female coupling member 180 and, conversely, to close the male coupling member 178 when disconnected from the female coupling member 180.


In this case, the male coupling member 178 includes a projection 182 which is fixed to the body 172. A sheath portion 184 encircles the projection 182 and is also fixed to the body 172. The sheath portion 184 and is spaced from the projection 182 to form a passage 186 to receive the female coupling member 180.


A valve member 190 is movable relative to the projection 182 and forms a fluid channel 192 there between and sealed by an inner seal 193. The projection 182 includes an inner passage 194 which has one end 194a open to the chamber 174 and another end 194b which is open to the fluid channel 192.


Referring to FIGS. 14 and 15, the projection includes an enlarged end portion 198 and the valve member 190 has an outer portion 200 arranged to engage the enlarged end portion 198 to close the fluid channel 192. In this case, the passage 186 ends at an inner wall 202 and the valve member 190 is movable relative to the inner wall 202 under the action of a spring 203 which is positioned in the passage 186 between the valve member 190 and the inner wall 202 to bias the outer end portion 200 of the valve member 190 toward an engaged position with the enlarged end portion 198.


As can be seen in FIG. 15, the enlarged end portion 198 and the outer end portion 200 on the valve member 190 have mating bevelled surfaces 198a and 200a respectively.


The valve member 190 is operable to engage the female coupling member 180 and to travel with the female coupling member 180 along the passage 186. In this case, the female coupling member 180 has a leading segment 180a and the outer end portion 200 of the valve member 190 is dimensioned to fit within the leading segment 180a.


In contrast to the device 120 of FIG. 6, the device 170 has a valve member 190 which is biased to the closed position. As the female coupling member 180 passes over the projection 182, the leading segment 180a of the female coupling member 180 rides over the outer end portion 200 of the valve element 190. Continued inward displacement of the female coupling member 180 into the passage 186 thus causes the valve member to move relative to the projection 182 until the mating bevelled surfaces 198a, 202a separate to open the fluid channel 192 to the needle. The fluid coupling is thus fully operational when the female and male coupling members are tightly engaged. When the female coupling member 180 is removed from the male coupling member 178, the valve member 190 is returned to its closed position against the projection 198 under the biasing action of the spring 203, to close the male coupling member.


While the present invention has been described for what are presently considered the preferred embodiments, the invention is not so limited. To the contrary, the invention is intended to cover various modifications and equivalent arrangements included within the spirit and scope of the appended claims. The scope of the following claims is to be accorded the broadest interpretation so as to encompass all such modifications and equivalent structures and functions.


The valve unit may be used with other medical fluid delivery devices, such as IV lines, catheters, infusion pumps and the like. The valve unit may also be used on syringes and other medical devices which do not employ the ubiquitous luer coupling arrangement.

Claims
  • 1. A medical connector comprising: housing comprising: a male luer end portion with an opening, andan internal thread on an interior surface of the housing near the opening, the internal thread configured to receive a separate medical connector;a female luer end portion positioned in a proximal region of the medical connector, the female luer end portion comprising an external thread on an outer surface of the female luer end portion, and the female luer end portion being configured to receive a male luer;a valve member comprising: a generally tubular body with a proximal portion and a distal portion;a valve lumen extending inside the generally tubular body from the distal portion of the generally tubular body to the proximal portion of the generally tubular body; anda plug at a distal end of the valve lumen;wherein the generally tubular body has a first position configured to inhibit fluid flow through the generally tubular body to or from the separate medical connector, and the generally tubular body has a second position configured to allow fluid flow through the generally tubular body to or from the separate medical connector,wherein the generally tubular body is biased to the first position; andan actuating biasing member positioned between the male luer end portion and the internal thread on the interior surface of the housing, the actuating member and configured to actuate the generally tubular body from the first position to the second position,wherein the actuating member is coupled to the valve member at a location proximal from the plug.
  • 2. The medical connector of claim 1, wherein the actuating member actuates the generally tubular body when the separate medical connector engages the housing.
  • 3. The medical connector of claim 1, wherein the valve member comprises an anchor flange, wherein the actuating member is coupled to the anchor flange.
  • 4. The medical connector of claim 1, wherein the male luer end portion of the housing extends further in the distal direction than the internal thread on the interior surface of the housing.
  • 5. The medical connector of claim 1, wherein the valve member is positioned within the housing.
  • 6. The medical connector of claim 5, wherein the plug on the valve member has an outer surface that is tapered.
  • 7. The medical connector of claim 6, wherein the valve lumen extends within the valve member from the plug to the female luer end portion.
  • 8. The medical connector of claim 1, wherein the valve member further comprises lateral side openings adjacent the plug and in fluid communication with the valve lumen.
  • 9. The medical connector of claim 1, wherein the plug is positioned within the opening of the male luer end portion.
  • 10. The medical connector of claim 1, wherein the male luer end portion further comprises a central fluid channel and the opening is positioned at an end of the central fluid channel.
  • 11. The medical connector of claim 10, wherein the central fluid channel is positioned within and extends distally past the internal thread.
  • 12. The medical connector of claim 10, wherein the central fluid channel comprises a valve seat.
  • 13. The medical connector of claim 12, wherein the plug is movable relative to the valve seat and configured to engage the valve seat to inhibit fluid flow through the central fluid channel when the generally tubular body is in the first position.
  • 14. The medical connector of claim 1, wherein the male luer configured to be received by the female luer end portion further comprises a syringe.
  • 15. The medical connector of claim 1, wherein the valve member is integrally formed with the female luer end portion.
  • 16. The medical connector of claim 1, wherein the actuating member comprises at least one abutment element configured to engage with the separate medical connector.
  • 17. A fluid communication system comprising the medical connector of claim 1 in combination with the separate medical connector.
CROSS-REFERENCE TO RELATED APPLICATIONS

This application is a continuation of application Ser. No. 13/305,663, filed Nov. 28, 2011, now U.S. Pat. No. 8,556,868, which is a continuation of application Ser. No. 12/789,255, filed May 27, 2010, now U.S. Pat. No. 8,066,692, which is a continuation of application Ser. No. 10/584,920, filed Dec. 28, 2006, now U.S. Pat. No. 7,758,566, which is the National Stage Entry of International Application No. PCT/US04/42723, filed Dec. 21, 2004, which claims the benefit of U.S. Provisional Application No. 60/532,916, filed Dec. 30, 2003; the entire contents of all of which are hereby incorporated by reference herein and made a part of this specification. Any and all priority claims identified in the Application Data Sheet, or any correction thereto, are hereby incorporated by reference under 37 CFR 1.57.

US Referenced Citations (307)
Number Name Date Kind
2842382 Franck Jul 1958 A
2931668 Baley Apr 1960 A
2968497 Treleman Jan 1961 A
3127892 Bellamy, Jr. et al. Apr 1964 A
3304047 Martin Feb 1967 A
3334860 Bolton, Jr. Aug 1967 A
3707972 Villari et al. Jan 1973 A
3729031 Baldwin Apr 1973 A
3986508 Barrington Oct 1976 A
4055179 Manschot et al. Oct 1977 A
4066067 Micheli Jan 1978 A
4076285 Martinez Feb 1978 A
4080965 Phillips Mar 1978 A
4084606 Mittleman Apr 1978 A
4121585 Becker, Jr. Oct 1978 A
4133441 Mittleman et al. Jan 1979 A
4143853 Abramson Mar 1979 A
4150845 Kopacz et al. Apr 1979 A
4195632 Parker et al. Apr 1980 A
4233982 Bauer et al. Nov 1980 A
4245635 Kontos Jan 1981 A
4324239 Gordon et al. Apr 1982 A
4334551 Pfister Jun 1982 A
4340049 Munsch Jul 1982 A
4379458 Bauer et al. Apr 1983 A
4387879 Tauschinski Jun 1983 A
4397442 Larkin Aug 1983 A
4430073 Bemis et al. Feb 1984 A
4436125 Blenkush Mar 1984 A
4457749 Bellotti et al. Jul 1984 A
4511359 Vaillancourt Apr 1985 A
4538836 Kruetten Sep 1985 A
4610469 Wolff-Mooij Sep 1986 A
4619640 Potolsky et al. Oct 1986 A
4623332 Lindmayer et al. Nov 1986 A
4629159 Wellenstam Dec 1986 A
4660803 Johnston et al. Apr 1987 A
4662878 Lindmayer May 1987 A
4700744 Rutter et al. Oct 1987 A
4723603 Plummer Feb 1988 A
4728075 Paradis Mar 1988 A
4745950 Mathieu May 1988 A
4774964 Bonaldo Oct 1988 A
4774965 Rodriguez et al. Oct 1988 A
4781702 Herrli Nov 1988 A
4804015 Albinsson Feb 1989 A
4816024 Sitar et al. Mar 1989 A
4819692 Olson et al. Apr 1989 A
4834271 Litwin May 1989 A
4862913 Wildfang Sep 1989 A
4883483 Lindmayer Nov 1989 A
4915687 Sivert Apr 1990 A
4917669 Bonaldo Apr 1990 A
4935010 Cox et al. Jun 1990 A
4950260 Bonaldo Aug 1990 A
D313277 Haining Dec 1990 S
D314050 Sone Jan 1991 S
5006114 Rogers et al. Apr 1991 A
5021059 Kensey et al. Jun 1991 A
5047021 Utterberg Sep 1991 A
5065783 Ogle, II Nov 1991 A
5070885 Bonaldo Dec 1991 A
5098385 Walsh Mar 1992 A
5108376 Bonaldo Apr 1992 A
5122123 Vaillancourt Jun 1992 A
5139483 Ryan Aug 1992 A
5147333 Raines Sep 1992 A
5154703 Bonaldo Oct 1992 A
RE34223 Bonaldo Apr 1993 E
5199948 McPhee Apr 1993 A
5201725 Kling Apr 1993 A
5203775 Frank et al. Apr 1993 A
5211634 Vaillancourt May 1993 A
5215537 Lynn et al. Jun 1993 A
5215538 Larkin Jun 1993 A
5242393 Brimhall et al. Sep 1993 A
5242425 White et al. Sep 1993 A
5251873 Atkinson et al. Oct 1993 A
5269771 Thomas et al. Dec 1993 A
5273533 Bonaldo Dec 1993 A
5279571 Larkin Jan 1994 A
5281206 Lopez Jan 1994 A
5284475 Mackal Feb 1994 A
5295657 Atkinson Mar 1994 A
5301686 Newman Apr 1994 A
5306243 Bonaldo Apr 1994 A
5312377 Dalton May 1994 A
5324270 Kayan et al. Jun 1994 A
5330450 Lopez Jul 1994 A
5334159 Turkel Aug 1994 A
5344414 Lopez et al. Sep 1994 A
5360413 Leason et al. Nov 1994 A
5370636 Von Witzleben Dec 1994 A
5380306 Brinon Jan 1995 A
5385372 Utterberg Jan 1995 A
5390898 Smedley et al. Feb 1995 A
5391150 Richmond Feb 1995 A
5395348 Ryan Mar 1995 A
5397314 Farley et al. Mar 1995 A
5400500 Behnke et al. Mar 1995 A
5401245 Haining Mar 1995 A
5402826 Molnar et al. Apr 1995 A
5402982 Atkinson et al. Apr 1995 A
5405323 Rogers et al. Apr 1995 A
5405331 Behnke et al. Apr 1995 A
5405333 Richmond Apr 1995 A
5411499 Dudar et al. May 1995 A
5417673 Gordon May 1995 A
5423791 Bartlett Jun 1995 A
5425465 Healy Jun 1995 A
5433330 Yatsko et al. Jul 1995 A
5439451 Collinson et al. Aug 1995 A
5441487 Vedder Aug 1995 A
5445623 Richmond Aug 1995 A
5447177 Ricken et al. Sep 1995 A
5456668 Ogle, II Oct 1995 A
5456675 Wolbring et al. Oct 1995 A
5462255 Rosen et al. Oct 1995 A
5464399 Boettger Nov 1995 A
5470319 Mayer Nov 1995 A
5470327 Helgren et al. Nov 1995 A
5474536 Bonaldo Dec 1995 A
5480393 Bommarito Jan 1996 A
5489274 Chu Feb 1996 A
5492147 Challender et al. Feb 1996 A
5501426 Atkinson et al. Mar 1996 A
5507744 Tay et al. Apr 1996 A
5514177 Kurz et al. May 1996 A
5518026 Benjey May 1996 A
5520665 Fleetwood May 1996 A
5520666 Choudhury et al. May 1996 A
5527284 Ohnemus et al. Jun 1996 A
5533708 Atkinson et al. Jul 1996 A
5533983 Haining Jul 1996 A
5535785 Werge et al. Jul 1996 A
5540661 Tomisaka et al. Jul 1996 A
5549566 Elias et al. Aug 1996 A
5549577 Siegel et al. Aug 1996 A
5549651 Lynn Aug 1996 A
5552118 Mayer Sep 1996 A
5555908 Edwards et al. Sep 1996 A
5569235 Ross et al. Oct 1996 A
5573516 Tyner Nov 1996 A
5575769 Vaillancourt Nov 1996 A
5578059 Patzer Nov 1996 A
5584819 Kopfer Dec 1996 A
5591137 Stevens Jan 1997 A
5591143 Trombley, III et al. Jan 1997 A
5597536 Mayer Jan 1997 A
5616129 Mayer Apr 1997 A
5616130 Mayer Apr 1997 A
RE35539 Bonaldo Jun 1997 E
5643224 Szapiro et al. Jul 1997 A
5645538 Richmond Jul 1997 A
5674206 Allton et al. Oct 1997 A
5676346 Leinsing Oct 1997 A
5685868 Lundquist Nov 1997 A
5699821 Paradis Dec 1997 A
5700248 Lopez Dec 1997 A
5702374 Johnson Dec 1997 A
5709243 Wells et al. Jan 1998 A
5735826 Richmond Apr 1998 A
5738144 Rogers Apr 1998 A
5749861 Guala et al. May 1998 A
RE35841 Frank et al. Jul 1998 E
5782816 Werschmidt et al. Jul 1998 A
5785693 Haining Jul 1998 A
5806831 Paradis Sep 1998 A
5814024 Thompson et al. Sep 1998 A
5820601 Mayer Oct 1998 A
5839715 Leinsing Nov 1998 A
5848994 Richmond Dec 1998 A
5947954 Bonaldo Sep 1999 A
6029946 Doyle Feb 2000 A
6036171 Weinheimer et al. Mar 2000 A
6039302 Cote, Sr. et al. Mar 2000 A
6041805 Gydesen et al. Mar 2000 A
6050978 Orr et al. Apr 2000 A
6063062 Paradis May 2000 A
6068011 Paradis May 2000 A
6068617 Richmond May 2000 A
6079432 Paradis Jun 2000 A
6106502 Richmond Aug 2000 A
6113068 Ryan Sep 2000 A
6142446 Leinsing Nov 2000 A
6152913 Feith et al. Nov 2000 A
6168137 Paradis Jan 2001 B1
6170522 Tanida Jan 2001 B1
6171287 Lynn et al. Jan 2001 B1
6189859 Rohrbough et al. Feb 2001 B1
6206860 Richmond Mar 2001 B1
6224578 Davis et al. May 2001 B1
6242393 Ishida et al. Jun 2001 B1
6245048 Fangrow et al. Jun 2001 B1
6290206 Doyle Sep 2001 B1
6299132 Weinheimer et al. Oct 2001 B1
6402207 Segal et al. Jun 2002 B1
6428520 Lopez Aug 2002 B1
6431219 Redler et al. Aug 2002 B1
6485472 Richmond Nov 2002 B1
6499719 Clancy et al. Dec 2002 B1
6508792 Szames et al. Jan 2003 B2
6508807 Peters Jan 2003 B1
6541802 Doyle Apr 2003 B2
6543745 Enerson Apr 2003 B1
6581906 Pott et al. Jun 2003 B2
6585229 Cote et al. Jul 2003 B2
6595964 Finley et al. Jul 2003 B2
6595981 Huet Jul 2003 B2
6609696 Enerson Aug 2003 B2
6612624 Segal et al. Sep 2003 B1
6666852 Niedospial, Jr. Dec 2003 B2
6695817 Fangrow Feb 2004 B1
6745998 Doyle Jun 2004 B2
6840501 Doyle Jan 2005 B2
6869426 Ganem Mar 2005 B2
6875205 Leinsing Apr 2005 B2
6899315 Mailville et al. May 2005 B2
6955669 Curutcharry Oct 2005 B2
6964406 Doyle Nov 2005 B2
7004934 Vaillancourt Feb 2006 B2
7037302 Vaillancourt May 2006 B2
7040598 Raybuck May 2006 B2
7044441 Doyle May 2006 B2
7100891 Doyle Sep 2006 B2
7125396 Leinsing et al. Oct 2006 B2
7137654 Segal et al. Nov 2006 B2
7140592 Phillips Nov 2006 B2
7182313 Doyle Feb 2007 B2
7195228 Tiberghien et al. Mar 2007 B2
7244249 Leinsing et al. Jul 2007 B2
7306197 Parrino et al. Dec 2007 B2
7306198 Doyle Dec 2007 B2
7306566 Raybuck Dec 2007 B2
7347458 Rome et al. Mar 2008 B2
7350764 Raybuck Apr 2008 B2
7361164 Simpson et al. Apr 2008 B2
7497484 Ziman Mar 2009 B2
7559530 Korogi et al. Jul 2009 B2
7588563 Guala Sep 2009 B2
7645274 Whitley Jan 2010 B2
7651481 Raybuck Jan 2010 B2
7666170 Guala Feb 2010 B2
7758566 Simpson et al. Jul 2010 B2
7766304 Phillips Aug 2010 B2
7766897 Ramsey et al. Aug 2010 B2
7803139 Fangrow, Jr. Sep 2010 B2
7803140 Fangrow, Jr. Sep 2010 B2
7815614 Fangrow, Jr. Oct 2010 B2
7837658 Cote et al. Nov 2010 B2
7857805 Raines Dec 2010 B2
7976532 Kitani et al. Jul 2011 B2
7998134 Fangrow et al. Aug 2011 B2
8066692 Simpson et al. Nov 2011 B2
8211069 Fangrow, Jr. Jul 2012 B2
8225826 Horppu et al. Jul 2012 B2
8262628 Fangrow, Jr. Sep 2012 B2
8286936 Kitani et al. Oct 2012 B2
8287513 Ellstrom et al. Oct 2012 B2
8454579 Fangrow, Jr. Jun 2013 B2
8556868 Simpson et al. Oct 2013 B2
8721628 Ziman May 2014 B2
9168366 Fangrow et al. Oct 2015 B2
20030066978 Enerson Apr 2003 A1
20030136932 Doyle Jul 2003 A1
20030208165 Christensen et al. Nov 2003 A1
20040074541 Sharpe Apr 2004 A1
20040124388 Kiehne Jul 2004 A1
20040124389 Phillips Jul 2004 A1
20040244848 Maldavs Dec 2004 A1
20050015075 Wright et al. Jan 2005 A1
20050124942 Richmond Jun 2005 A1
20050228362 Vaillancourt Oct 2005 A1
20060025751 Roy et al. Feb 2006 A1
20060058734 Phillips Mar 2006 A1
20060065873 Doyle Mar 2006 A1
20060129109 Shaw et al. Jun 2006 A1
20060142730 Proulx et al. Jun 2006 A1
20060142735 Whitley Jun 2006 A1
20060157984 Rome et al. Jul 2006 A1
20060161115 Fangrow Jul 2006 A1
20060202146 Doyle Sep 2006 A1
20060253084 Nordgren Nov 2006 A1
20070043334 Guala Feb 2007 A1
20070073270 Christensen et al. Mar 2007 A1
20070088292 Fangrow Apr 2007 A1
20070088293 Fangrow Apr 2007 A1
20070088294 Fangrow Apr 2007 A1
20070088327 Guala Apr 2007 A1
20070179453 Lim et al. Aug 2007 A1
20080103485 Kruger May 2008 A1
20080190485 Guala Aug 2008 A1
20080290657 McKeon, III Nov 2008 A1
20100063482 Mansour et al. Mar 2010 A1
20100174242 Anderson et al. Jul 2010 A1
20100253070 Cheon et al. Oct 2010 A1
20110306931 Kamen et al. Dec 2011 A1
20120031515 Whitaker Feb 2012 A1
20120041391 Fangrow et al. Feb 2012 A1
20120089101 Carlyon et al. Apr 2012 A1
20120316536 Carrez et al. Dec 2012 A1
20130035668 Kitani et al. Feb 2013 A1
20130317483 Reichart et al. Nov 2013 A1
20150051555 Fangrow, Jr. Feb 2015 A1
20160213910 Fangrow, Jr. et al. Jul 2016 A1
20160263367 Fangrow et al. Sep 2016 A1
20160271327 Simpson et al. Sep 2016 A1
Foreign Referenced Citations (33)
Number Date Country
2747283 Jul 2002 CA
0 158 030 Oct 1986 EP
0 368 473 May 1990 EP
0 791 371 Aug 1997 EP
0 795 342 Sep 1997 EP
1 946 792 Jul 2008 EP
2 116 277 Sep 1983 GB
2 118 440 Nov 1983 GB
2 353 078 Feb 2001 GB
56-72659 Jun 1981 JP
59-41429 Mar 1984 JP
59-138532 Aug 1984 JP
60-89488 Jun 1985 JP
63-175383 Nov 1988 JP
11-311324 Nov 1999 JP
2004-000483 Jan 2004 JP
2001-187990 Jul 2007 JP
WO 9532748 Dec 1995 WO
WO 0103756 Jan 2001 WO
WO 0123026 Apr 2001 WO
WO 0296500 Dec 2002 WO
WO 03013646 Feb 2003 WO
WO 2004060474 Jul 2004 WO
WO 2004082756 Sep 2004 WO
WO 2006076656 Jul 2006 WO
WO 2006088858 Aug 2006 WO
WO 2006124756 Nov 2006 WO
WO 2007008511 Jan 2007 WO
WO 2007112944 Oct 2007 WO
WO 2008144447 Nov 2008 WO
WO 2010071848 Jun 2010 WO
WO 2011139995 Nov 2011 WO
WO 2013036854 Mar 2013 WO
Non-Patent Literature Citations (12)
Entry
International Search Report for International Application No. PCT/US2004/042723, Notification mailed on Jun. 28, 2005 in 5 pages.
Air Embolism and Exsanguination from Separation of Two-Piece Side Port/Hemostasis Valve Cardiac Catheter Introducers, ECRI Institute, Jan. 1995, in 2 pages, http://www.mdsr.ecri.org/summary/detail.aspx?doc—id=8098.
EPO Examination Report re EP Application No. 08 755 612.2, dated Nov. 20, 2013 in 5 pages.
EPO Examination Report re EP Application No. 08 755 612.2, dated Dec. 5, 2012 in 6 pages.
EPO Search Report re EP Application No. 08 755 612.2, dated Feb. 23, 2012 in 5 pages.
Injection Site, Molded Products, Inc., Apr. 2, 2004, in 1 page, https://web.archive.org/web/20040402123354/https://www.moldedproducts.com/injectionsite.htm.
International Preliminary Report on Patentability, International Application No. PCT/US2008/063797 mailed on Nov. 17, 2009 in 11 pages.
International Search Report and Written Opinion of International Application No. PCT/US2008/063797 mailed on Dec. 30, 2008 in 21 pages.
International Search Report for PCT/US2006/026124, dated Mar. 3, 2007 in 5 pgs.
International Written Opinion for PCT/US2006/026124, dated Jan. 10, 2008 in 11 pgs.
International Search Report and Written Opinion for International Application No. PCT/US2004/042723, issued on Jun. 28, 2005 in 16 pages.
International Search Report of International Application No. PCT/US2004/042723 issued on Jun. 28, 2005 in 5 pages.
Related Publications (1)
Number Date Country
20140228777 A1 Aug 2014 US
Provisional Applications (1)
Number Date Country
60532916 Dec 2003 US
Continuations (3)
Number Date Country
Parent 13305663 Nov 2011 US
Child 14052592 US
Parent 12789255 May 2010 US
Child 13305663 US
Parent 10584920 US
Child 12789255 US